weightloss.com.au
Head-to-head comparison

Compare Orlistat vs. Ozempic

Orlistat and Ozempic represent opposite ends of the weight loss medication spectrum in Australia. Orlistat is the most accessible option, available over-the-counter at $50-80/month, but produces modest weight loss (~3-5%) by blocking fat absorption. Ozempic is a prescription GLP-1 injection producing ~15% weight loss, but is PBS-subsidised only for diabetes.

Orlistat logo
Orlistat
Orlistat 60mg (OTC) / 120mg (Rx)
~3-5%
avg. weight loss
$50-80 (OTC available)
per month
Ozempic logo
Ozempic
Semaglutide 0.25-1mg
~15%
avg. weight loss
$32 PBS / $134 private
per month

Compare Orlistat vs Ozempic at a Glance

Drug class
Orlistat
Lipase inhibitor
Ozempic
GLP-1 receptor agonist
How taken
Orlistat
Oral capsule with meals (up to 3x daily)
Ozempic
Weekly injection
Avg. weight loss
Orlistat
~3-5%
Ozempic
~15%
First approved
Orlistat
1999 (FDA), 2000 (TGA)
Ozempic
2017 (FDA), 2019 (TGA)
AU cost/month
Orlistat
$50-80 (OTC available)
Ozempic
$32 PBS / $134 private
PBS status
Orlistat
No
Ozempic
Yes (diabetes only)
Prescription needed?
Orlistat
OTC (60mg) / Rx (120mg)
Ozempic
Yes
AU supply status
Orlistat
Widely available
Ozempic
Constrained (improving)

Compare Orlistat vs Ozempic Cost in Australia

Orlistat
$50–80
$50-80 (OTC available)
per month
Ozempic
$32–134
$32 PBS / $134 private
per month (PBS: Yes (diabetes only))

Private prescription cost per month in AUD.

Compare Orlistat vs Ozempic Weight Loss Efficacy

Orlistat
~3-5%
avg. weight loss (2-6%)
Ozempic
~15%
avg. weight loss (10-17%)

Orlistat Clinical Trials

XENDOS

5.8kg loss vs 3kg placebo

4 yearsn=3,304

Multiple Phase 3

~3-5% body weight reduction

12-52 weeks

Ozempic Clinical Trials

SUSTAIN 1-12

5-7kg weight loss (diabetes population)

30-104 weeks

STEP 1 (higher dose)

14.9% body weight reduction

68 weeks

Clinical trial data at highest approved doses. Individual results vary.

Compare Orlistat vs Ozempic Side Effects

Orlistat

Very common

  • Oily/fatty stools
  • Oily spotting
  • Increased flatulence
  • Faecal urgency

Common

  • Abdominal discomfort
  • Liquid stools
  • Frequent bowel movements
  • Headache

Serious (rare)

  • Liver injury (very rare)
  • Kidney stones (rare)
  • Reduced fat-soluble vitamin absorption (A,D,E,K)
  • May affect absorption of some medications

Ozempic

Very common

  • Nausea (20-44%)
  • Diarrhoea (8-30%)
  • Vomiting

Common

  • Constipation
  • Abdominal pain
  • Headache
  • Fatigue
  • Injection site reactions

Serious (rare)

  • Pancreatitis
  • Gallbladder problems
  • Kidney injury
  • Thyroid tumours (animal studies)
  • Suicidal ideation (under investigation)

Compare How Orlistat and Ozempic Work

Orlistat

Lipase inhibitor

Completely different mechanism to GLP-1 drugs. Inhibits gastric and pancreatic lipase enzymes, preventing approximately 30% of dietary fat from being absorbed. Unabsorbed fat passes through the digestive system. Does not affect appetite or the brain. Most effective with a reduced-fat diet.

Ozempic

GLP-1 receptor agonist

Mimics the natural hormone GLP-1. Slows gastric emptying, increases insulin production, reduces glucagon, and acts on appetite centres in the brain to reduce hunger. Once-weekly injection in abdomen, thigh, or upper arm.

Compare Orlistat vs Ozempic Dosing Schedule

Orlistat

Oral capsule with meals (up to 3x daily)

DosePeriodNote
60mg OTCWith each mealUp to 3 capsules/day
120mg RxWith each mealUp to 3 capsules/day

Ozempic

Weekly subcutaneous injection

DosePeriodNote
0.25mgWeeks 1-4Starting dose
0.5mgWeeks 5-8Dose escalation
1mgWeek 9+Maintenance dose

Compare Orlistat vs Ozempic Australian Regulatory Status

Orlistat

TGA Status
Registered (OTC and prescription strengths)
PBS Listed
No PBS listing
OTC Availability
60mg available without prescription at pharmacies
Key Advantage
No needles, no Rx for lower dose, cheapest option, longest safety record
Limitation
Modest weight loss vs GLP-1 drugs; GI side effects related to fat intake

Ozempic

TGA Status
Registered on ARTG for type 2 diabetes
PBS Listed
Yes, for type 2 diabetes (Authority Required)
Off-label Use
Restricted since Oct 2024 for new weight loss prescriptions
Supply Status
Ongoing shortage since 2022; improving but not resolved
Compounding
Compounded versions banned from 1 October 2024

This website is for informational and research purposes only.

We are not medical professionals and nothing on this page constitutes medical advice, diagnosis, or treatment. Always consult a qualified doctor or specialist before making any decisions about medication.

The weight loss medication landscape in Australia is changing rapidly. Information on this page may become outdated without notice. Data sourced from the TGA, FDA, MHRA, NICE, PBAC, Australian Prescriber, Obesity Evidence Hub, and clinical trial publications. Last reviewed March 2026.